Compare VanEck Gold Miners ETF (GDX) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Gold Miners ETF vs Zoetis Inc — how do they compare? VanEck Gold Miners ETF trades at $71.43, while Zoetis Inc trades at $77.18 (market cap $31.25B). The key difference: Zoetis Inc pays a 2.84% dividend while VanEck Gold Miners ETF pays none, and VanEck Gold Miners ETF is trading nearer its 52-week high, Zoetis Inc nearer its low. Which is the better fit depends on your goals.
| GDX | ZTS | |
|---|---|---|
52-Week High | $115.84 | $156.76 |
52-Week Low | $51.15 | $71.91 |
Market Cap | — | $31.25B |
Sector | — | Health |
Enterprise Value | — | $38.54B |
Dividend Yield | — | 2.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GDX (VanEck Gold Miners ETF) trades at $71.42, down 4.62% with bearish technical signals from moving averages. The fund faces competition from lower-fee gold ETFs while offering mining equity exposure with higher volatility. Recent portfolio changes include the addition of Aya Gold & Silver, potentially enhancing diversification. Technical indicators show neutral oscillators but overall bearish momentum with key support at $70.
The outlook remains cautious as gold miners navigate gold price volatility and fee competition. Upside potential exists if gold rebounds, but investors face risks from sector underperformance relative to physical gold. Analyst views are mixed, with some seeing value in discounted valuations while others highlight structural challenges in the mining ETF space.
Zoetis (ZTS) trades at $77.13, up 4.12% in the last session, with a bearish technical signal from moving averages. The company reported strong 2025 results, including $9.47B revenue and $2.67B net income, with high profitability margins. Recent news highlights a securities class action lawsuit and the launch of Lenivia in Canada and the EU. Cash flow improved to a positive $325M in 2025, though net cash flow is projected to decline in 2026.
The stock presents a mixed outlook: strong fundamentals and a consensus price target of $101.43 suggest upside, but legal risks and bearish technicals pose near-term headwinds. Earnings momentum is key, with Q2 2026 results critical after a Q1 miss. Institutional sentiment is cautious despite no sell ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VanEck Gold Miners ETF
The fund normally invests at least 80% of its total assets in common stocks and depositary receipts of companies involved in the gold mining industry. The index is a modified market-capitalization weighted index primarily comprised of publicly traded companies involved in the mining for gold and silver. The fund is non-diversified.
Read more on GDX →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
